Seres Therapeutics, Inc. · Brief

Next report

4 days

Nov 4 · before openest.Q3 FY26

Expected move

±36.0%implied · straddle

1.132.41

spot 1.77exp Nov 20ATM strike 2.5ATM straddle 0.75IV 79%

Oct 30 close

Expected move

—≥ implied

Q2 FY26±41.0%▼−4.67%×0.11

quarterimplied−45%0+45%realized×

Q2 FY26±41.0%▼−4.67%×0.11

Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close

Nov 4 report · est.

Bull1

34managers reporting a position in the latest quarterly filings13F · Jun 30 '26

Bear1

9 of 22largest reporting managers cut their stake in the latest quarter13F · Jun 30 '26

AI captions · Oct 26 '26once per report · top 2 per case

MCRB report session

No linked exposure.

Oct 21impliedImplied move: ±24.4% into Nov 4 earnings (Oct 21 close).Source

privateThesis 0 · Decisions 0 · Observations 0

No thesis.